Showing results (101-110 of 208) with videos related to
Sort By:
Pageof 21
Oncogene|March 27, 2018
Protein kinase A-mediated phosphorylation regulates STAT3 activation and oncogenic EZH2 activityAli R Özeş, Nick Pulliam, Mustafa G Ertosun, et al.BMC Genomics|April 17, 2008
Identification of transcription factor and microRNA binding sites in responsible to fetal alcohol syndromeGuohua Wang, Xin Wang, Yadong Wang, et al.BMC Medical Genomics|June 10, 2009
Integrated analysis of DNA methylation and gene expression reveals specific signaling pathways associated with platinum resistance in ovarian cancerMeng Li, Curt Balch, John S Montgomery, et al.Oncotarget|November 23, 2017
The novel ZIP4 regulation and its role in ovarian cancerQipeng Fan, Qingchun Cai, Pengfei Li, et al.Comparative and Functional Genomics|September 8, 2012
Empirical bayes model comparisons for differential methylation analysisMingxiang Teng, Yadong Wang, Seongho Kim, et al.Cancer Research|May 3, 2003
Triple analysis of the cancer epigenome: an integrated microarray system for assessing gene expression, DNA methylation, and histone acetylationHuidong Shi, Susan H Wei, Yu-Wei Leu, et al.NPJ Precision Oncology|December 17, 2019
Interferon-γ signaling is associated with BRCA1 loss-of-function mutations in high grade serous ovarian cancerHoracio Cardenas, Guanglong Jiang, Jessica Thomes Pepin, et al.Cancer Research|December 13, 2017
Genomic and Epigenomic Signatures in Ovarian Cancer Associated with Resensitization to Platinum DrugsFang Fang, Horacio Cardenas, Hao Huang, et al.Molecular Carcinogenesis|May 11, 2013
SERPINB2 down-regulation contributes to chemoresistance in head and neck cancerZhiquan Huang, Haigang Li, Qi Huang, et al.Plos One|July 30, 2011
ChIP-seq defined genome-wide map of TGFβ/SMAD4 targets: implications with clinical outcome of ovarian cancerBrian A Kennedy, Daniel E Deatherage, Fei Gu, et al.Pageof 21